Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study

Asthma is a chronic inflammatory airway disease, representing one of the most severe pathologies in developed countries. Based on a report of the World Health Organization (WHO), it affects about 300 million people worldwide. Few studies have analyzed the effects of daily life physical activity (PA)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Carpagnano, Giovanna Elisiana, Sessa, Francesco, Scioscia, Giulia, Lacedonia, Donato, Foschino, Maria Pia, Venuti, Maria Pia, Triggiani, Antonio Ivano, Valenzano, Anna, Resta, Onofrio, Cibelli, Giuseppe, Messina, Giovanni
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6992710/
https://ncbi.nlm.nih.gov/pubmed/32038267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01630
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars